0001785460-21-000001.txt : 20210324 0001785460-21-000001.hdr.sgml : 20210324 20210324122546 ACCESSION NUMBER: 0001785460-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20210324 DATE AS OF CHANGE: 20210324 EFFECTIVENESS DATE: 20210324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Meru Biotechnologies, Inc. CENTRAL INDEX KEY: 0001785460 IRS NUMBER: 834245825 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-379430 FILM NUMBER: 21767451 BUSINESS ADDRESS: STREET 1: 800 E LEIGH STREET CITY: RICHMOND STATE: VA ZIP: 23219 BUSINESS PHONE: 8666378246 MAIL ADDRESS: STREET 1: 800 E LEIGH STREET CITY: RICHMOND STATE: VA ZIP: 23219 FORMER COMPANY: FORMER CONFORMED NAME: Meru Biotechnologies, LLC DATE OF NAME CHANGE: 20190814 D/A 1 primary_doc.xml X0708 D/A LIVE 0001785460 Meru Biotechnologies, Inc. 800 E LEIGH STREET RICHMOND VA VIRGINIA 23219 8666378246 VIRGINIA Meru Biotechnologies, LLC Corporation true 2019 Daniel Rodenhaver 800 E. Leigh Street Richmond VA VIRGINIA 23219 Executive Officer Director Director and Chief Executive Officer Theresa Schaub 800 E. Leigh Street Richmond VA VIRGINIA 23219 Executive Officer Director Director and Chief Commercialization Officer Biotechnology Decline to Disclose 06c true 0001785460-20-000002 2020-10-19 false true false 0 First Liberties Securities, Inc. (dba First Liberties Financial) 14432 First Liberties Securities, Inc. (dba First Liberties Financial) 14432 369 Lexington Avenue Suite 341 New York NY NEW YORK 10017 All States false 1200000 200000 1000000 false 1 52000 true 0 The Broker Dealer (see Item 12) will receive 6.5% cash payment, plus warrants, and so may receive up to $52,000 if the full amount of the offering is subscribed. No commission is due with respect to the the first $200,000 sold. 0 true Proceeds will be used for general operations, which may include payment of officer compensation in the ordinary course of business. false Meru Biotechnologies, Inc. /s/ Daniel Rodenhaver Daniel Rodenhaver CEO 2021-03-24